NYMOX PHARMACEUTICAL CORP (NYMXF)
Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
Address
9900 CAVENDISH BLVD., SUITE 306
QUEBEC CANADA, A8 H4M 2V2
Founded
1995
Number of Employees
-
Website
http://www.nymox.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)